Bruce Cozadd, Jazz Pharmaceuticals CEO
December 17, 2024 03:42 PM EST
People
Pharma

Jazz Phar­ma­ceu­ti­cals CEO and co-founder Bruce Cozadd is re­tir­ing

Nicole DeFeudis

Editor

Jazz Phar­ma­ceu­ti­cals CEO Bruce Cozadd is ready to play his out­ro.

On Mon­day, Cozadd an­nounced plans to re­tire, near­ly 22 years …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Sage sues Bio­gen days af­ter $469M buy­out of­fer

FDA ap­proves As­traZeneca and Dai­ichi Sankyo’s ADC for breast can­cer de­spite lack of sur­vival ben­e­fit

Ozem­pic makes list for next round of Medicare drug price ne­go­ti­a­tions

#JPM25 live blog day 1: How will Trump 2.0 im­pact the bio­phar­ma in­dus­try? Scott Got­tlieb, Bob Nelsen share ...

What Trump's CMS can and can't change with the sec­ond round of drug price ne­go­ti­a­tions

Broad In­sti­tute pa­per of­fers po­ten­tial new frame­work for treat­ing Hunt­ing­ton’s dis­ease

A service from the Financial Times